Skip to Main Content

UMass Lowell scales back Fall 2020 plan to minimize students, employees on campus. View the plan for more info.

Find Research Funding

External Funding Opportunities in Response to COVID-19

Helpful Databases and Resources

OrganizationTitle / Link
Hanover ResearchCOVID-19/Coronavirus Resources
InfoEd Global/SPINGrant Alerts, Projections, Calendars & Webinars
MITRECOVID-19 Authorities, Contract Vehicles, and Initiatives

SponsorTitle / LinkFirst Available Due Date(s)Expiration DateNotes
Biomedical Advanced Research and Development Authority (BARDA)Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)April 30, 2020Oct. 31, 2020
Bill & Melinda Gates FoundationCOVID-19 Therapeutics AcceleratorTBA
Department Of Energy (DOE)Department of Energy Dear Colleague LetterMarch 18, 2020
Foundation for Contemporary ArtsEmergency GrantsProposals accepted on a rolling basis
National Center for Advancing Translational SciencesNotice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)June 5, 2020Oct. 17, 2020
National Institutes of Health (NIH)Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)April 6, 2020May 1, 2021Applications accepted on a rolling basis
NIAIDNotice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)March 25, 2020March 25, 2021Proposals accepted on a rolling basis
NIAIDNotice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)April 5, 2020April 5, 2021
National Institute of General Medical Sciences (NIGMS)Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2March 25, 2020June 6, 2021
NIHNotice of Special Interest (NOSI) Regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)Feb. 6, 2020Feb. 6, 2021Proposals accepted on a rolling basis
NIHCollaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed)Sept. 9, 2020Sept. 10, 2020
NIHNotice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel CoronavirusMarch 19, 2020March 31, 2021Supplement to existing awards
NIHNotice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)March 17, 2020Oct. 6, 2020
NIHUrgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement -  Clinical Trial Optional)Continuous submission
NIHInvestigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)May 13, 2020Jan. 14 2023
National Institute for Health Research (NIHR)Travel and Subsistence Funding to Support LMIC Engagement During the COVID-19 OutbreakMay 30, 2020Continuous submission
National Science Foundation (NSF)Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)Before submitting a RAPID proposal or supplemental funding request in response to this DCL, investigators must first contact one of the cognizant OAC program officers listed.
NSFColleague Letter on the Coronavirus Disease 2019 (COVID-19)Check with program officer.

Internal Funding Opportunities

For a complete list of internal funding opportunities, please see Internal Funding Sources.